Feldman J M
Res Commun Chem Pathol Pharmacol. 1981 Dec;34(3):389-98.
We evaluated the activity of phenylethanolamine-N-methyltransferase (PNMT) and dopamine-beta-hydroxylase (DBH) in 16 pheochromocytomas. Ten of the tumors were from patients with Multiple Endocrine Neoplasia and six of the tumors were from patients with sporadic pheochromocytomas. All of the pheochromocytomas contained PNMT and DBH activity. There was a significant correlation between PNMT activity and epinephrine concentration in the pheochromocytomas (r=0.61); there was no significant correlation between PNMT activity and norepinephrine concentration (r=0.38) or DBH activity and norepinephrine (r=0.06) or dopamine (r=0.31) concentration. In general, the patients with the highest PNMT activity in their pheochromocytomas tended to have paroxysmal (rather than sustained) hypertension and to excrete more E than NE in their urine.
我们评估了16例嗜铬细胞瘤中苯乙醇胺 - N - 甲基转移酶(PNMT)和多巴胺 - β - 羟化酶(DBH)的活性。其中10例肿瘤来自多内分泌腺瘤患者,6例肿瘤来自散发性嗜铬细胞瘤患者。所有嗜铬细胞瘤均含有PNMT和DBH活性。嗜铬细胞瘤中PNMT活性与肾上腺素浓度之间存在显著相关性(r = 0.61);PNMT活性与去甲肾上腺素浓度(r = 0.38)、DBH活性与去甲肾上腺素(r = 0.06)或多巴胺(r = 0.31)浓度之间均无显著相关性。总体而言,嗜铬细胞瘤中PNMT活性最高的患者往往患有阵发性(而非持续性)高血压,且尿中排泄的肾上腺素比去甲肾上腺素更多。